Select Page

Nikolaos Stefanis

Visiting Professor, Psychiatry

[email protected]

N/A

School of Medicine

Visiting Professor

Academic Qualifications

Qualification Year Awarding Institution Department Thesis title (Optional Entry)
Doctorate in Psychiatry (PhD equivalent) July 1997 National and Kapodistrian University of Athens Medical School. National and Kapodistrian University of Athens Medical School. Title of Thesis: DRD4 dopamine receptor mRNA in post-mortem schizophrenia brain.
January 1996 Title of completed training in the Speciality of   Psychiatry - Title issued by Directorate of Public Health and Hygiene, Ministry of Health in Greece. National and Kapodistrian University of Athens Medical School.
November 1981 - January 1988 National and Kapodistrian University of Athens Medical School. National and Kapodistrian University of Athens Medical School.

Employment History

Employer Location Position
National and Kapodistrian University of Athens Medical School (NKUAMS) Athens Professor of Psychiatry
University Mental Health Research Institute Greece vice-chairman
First Episode Psychosis Task Force within the World Federation of Societies of Biological Psychiatry chair

Publications

Exhibitions

Research Projects

Academic Consulting Services/Councils/Boards/Editorial Committees

Period Organization Title of Position or Service
since 2017 Central Council of Health of Greece ( ΚεΣΥ) Committee on Medical Specialties
since 2017 Central Council of Health of Greece ( ΚεΣΥ) Committee of Mental Health
since 2017 Central Council of Health of Greece ( ΚεΣΥ) Committee for the New Education Scheme in Psychiatry

Awards/International Recognition

Date Title Awarded by:
(November 1981) University of Athens Medical School Entry Distinction Admission, following national examinations (first out of 450 candidates).
(1993 - 1994) Onassion Foundation Scholarship  Awarded following submission of Thesis (Novel dopamine  receptors as a  target for schizophrenia) 10.000 pounds / year plus travelling expenses.
(09/1991 -09/1992). Maria Pantelis Lemos Foundation, One year Post - Doctorate Fellowship
(1998-2001). EKBAN 97 (1.2-107) from the General Secretariat of Research and Technology of the Greek Ministry of Development (July 1998). Principal Investigator: Nicholas C. Stefanis "Prospective study investigating the risk factors for developing psychosis in healthy conscripts in the Greek Airforce. A combined cognitive, personality related and genetic study". 204.133.280.00 drachmas (500,000 sterling equivalent) for four years
between 2000-06. INTERREG IIIA/PHARE CBC Greece- Bulgaria. Actions taken for the mental health of women of mountainous Xanthi. Interreg III is a European Community initiative which aimed to stimulate interregional cooperation in the EU The project was financed under the European Regional Development Fund (ERDF).Principal Investigator: Nicholas Stefanis   € 250.000 for two years.
Approved April 2009. FP7-HEALTH-2009 “European Network of National Schizophrenia Networks Studying Gene-Environment Interactions” (total 11,616,855 Euros for four years). Principal Investigator:  Prof Jim van Os. Chief investigator for Greece: N. Stefanis. Personal funding under negotiation due to relocation to Australia
Duration: 04/23/2010 - 03/31/2014. RO1 MH085018-01A2 from the National Institute of Mental Health (NIMH)-USA. Title: Identification of genetic determinants of Schizophrenia related Phenotypes. PI’s: Associate Prof.  Dimitris Avramopoulos and Prof. Nicholas C. Stefanis subcontract with University Mental Health Research Institute. $1.455.000.00
Australia (2011). The European Network of Schizophrenia Networks for the Study of Gene-Environment Interactions (EU-GEI) –Implementation in WA, Principle Investigator: Nicholas Stefanis: $75.000 from NMAHS and UWA in WA.
National representative (PI for Greece):  STEPS (Stepped Treatment-response Evaluation and Prediction in Schizophrenia) Horizon 2020 Societal Challenge-Health, demographic change and well-being. (Submitted  2014 # 633655-1).
Commencing 2014 National Representative (PI for Greece):  EULAST (European Long-acting Antipsychotics in Schizophrenia Trial) ClinicalTrials.gov Identifier: NCT02146547.

Other Achievements